Most patients describe the sensation as a brief pinch thats over in seconds
The result could further be an indication of a substantial and rising off-label prescribing of GLP-1 RAs, something which aligns with previous indications of an increasing off-label prescribing and misuse of GLP-1 RAs [28,29,30,31, 60], together with a media picture of substantial misuse which has been reported in recent years [23, 26, 27, 34, 36, 68]
Study: Risk of Parkinson Disease Among Patients With Restless Leg Syndrome
USA TODAY reviewed a random sample of 100 of the thousands of federal lawsuits to learn more about the patients suing these companies
These plans focus on addressing insulin resistance and hormonal imbalances, which are often key factors in the need for GLP-1 treatments